Tenaya Therapeutics SG&A Expense (Semi Annual) Insights

Tenaya Therapeutics, Inc. (TNYA)

0.6874 -0.01 (-1.04%) USD | NASDAQ | Apr 06, 15:11

View SG&A Expense (Semi Annual) for TNYA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (Semi Annual) Chart

Start Trial

View Historical Data

Start Trial

View SG&A Expense (Semi Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View SG&A Expense (Semi Annual) Benchmarks

Start Trial

Marker Therapeutics, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--
Vericel Corp.	--
BioMarin Pharmaceutical, Inc.	--